Clinical Trial Update: Good-first: B/F/TAF As First-line ART

View source ↗

Summary

This clinical trial update announces a study evaluating B/F/TAF as first-line antiretroviral therapy for HIV infection. The trial is currently recruiting at the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: HIV Infection | Status: RECRUITING